Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1968 Feb 29;127(3):411–429. doi: 10.1084/jem.127.3.411

MECHANISMS OF ACTIVATION OF C'1 ESTERASE IN HEREDITARY ANGIONEUROTIC EDEMA PLASMA IN VITRO

THE ROLE OF HAGEMAN FACTOR, A CLOT-PROMOTING AGENT

Virginia H Donaldson 1
PMCID: PMC2138464  PMID: 5299945

Abstract

The generation of C'1 esterase activity in siliconed plasma obtained from individuals with hereditary angioneurotic edema in remission tends to occur spontaneously, but can be hastened during its incubation with preparations of activated Hageman factor. This effect of activated Hageman factor could not be shown during its incubation with normal siliconed plasma, nor could consumption of normal serum inhibition of C'1 esterase be clearly shown. Soy bean trypsin inhibitor and heparin could impair this enhanced generation of C'1 esterase but neither inhibits the esterolytic function of C'1 esterase once formed. Trasylol was less effective in blocking this effect of activated Hageman factor. While the mechanism of the effect of activated Hageman factor upon C'1 activation remains obscure, it is apparent that some intermediate steps, possibly involving a kinin-forming system of plasma, may play a role.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  2. AUSTEN K. F., SHEFFER A. L. DETECTION OF HEREDITARY ANGIONEUROTIC EDEMA BY DEMONSTRATION OF A REDUCTION IN THE SECOND COMPONENT OF HUMAN COMPLEMENT. N Engl J Med. 1965 Apr 1;272:649–656. doi: 10.1056/NEJM196504012721301. [DOI] [PubMed] [Google Scholar]
  3. BECKER E. L., KAGEN L. THE PERMEABILITY GLOBULINS OF HUMAN SERUM AND THE BIOCHEMICAL MECHANISM OF HEREDITARY ANGIONEUROTIC EDEMA. Ann N Y Acad Sci. 1964 Aug 27;116:866–873. doi: 10.1111/j.1749-6632.1964.tb52552.x. [DOI] [PubMed] [Google Scholar]
  4. BELL W. N., ALTON H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954 Nov 6;174(4436):880–881. doi: 10.1038/174880a0. [DOI] [PubMed] [Google Scholar]
  5. Breckenridge R. T., Ratnoff O. D. The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide. J Clin Invest. 1965 Feb;44(2):302–314. doi: 10.1172/JCI105144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burdon K. L., Queng J. T., Thomas O. C., McGovern J. P. Observations on biochemical abnormalities in hereditary angioneurotic edema. J Allergy. 1965 Nov-Dec;36(6):546–557. doi: 10.1016/0021-8707(65)90192-9. [DOI] [PubMed] [Google Scholar]
  7. DAVIE E. W., RATNOFF O. D. WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. Science. 1964 Sep 18;145(3638):1310–1312. doi: 10.1126/science.145.3638.1310. [DOI] [PubMed] [Google Scholar]
  8. DONALDSON V. H., EVANS R. R. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. doi: 10.1016/0002-9343(63)90162-1. [DOI] [PubMed] [Google Scholar]
  9. DONALDSON V. H., ROSEN F. S. ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE. J Clin Invest. 1964 Nov;43:2204–2213. doi: 10.1172/JCI105094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dias da Silva W., Lepow I. H. Anaphylatoxin formation by purified human C'1 esterase. J Immunol. 1965 Dec;95(6):1080–1089. [PubMed] [Google Scholar]
  11. Donaldson V. H., Ratnoff O. D. Hageman factor: alterations in physical properties during activation. Science. 1965 Nov 5;150(3697):754–756. doi: 10.1126/science.150.3697.754. [DOI] [PubMed] [Google Scholar]
  12. Donaldson V. H., Rosen F. S. Hereditary angioneurotic edema: a clinical survey. Pediatrics. 1966 Jun;37(6):1017–1027. [PubMed] [Google Scholar]
  13. HAINES A. L., LEPOW I. H. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM. J Immunol. 1964 Mar;92:468–478. [PubMed] [Google Scholar]
  14. IATRIDIS S. G., FERGUSON J. H. Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system. J Clin Invest. 1962 Jun;41:1277–1287. doi: 10.1172/JCI104590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KAGEN L. J. SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS. Br J Exp Pathol. 1964 Dec;45:604–611. [PMC free article] [PubMed] [Google Scholar]
  16. KENT J. F., OTERO A. G., HARRIGAN R. E. Relative specificity of serologic tests for syphilis in Mycobacterium leprae infection. Am J Clin Pathol. 1957 May;27(5):539–545. doi: 10.1093/ajcp/27.5.539. [DOI] [PubMed] [Google Scholar]
  17. KOCH W. Relationship between air temperature and mean radiant temperature in thermal comfort. Nature. 1962 Nov 10;196:587–587. doi: 10.1038/196587a0. [DOI] [PubMed] [Google Scholar]
  18. KRAUT H., BHARGAVA N. VERSUCHE ZUR ISOLIERUNG DES KALLIKREIN-INAKTIVATORS. V. ISOLIERUNG EINES KALLIKREIN-INAKTIVATORS AUS RINDERLUNGE UND SEINE IDENTIFIZIERUNG MIT DEM INAKTIVATOR AUS RINDERPAROTIS. Hoppe Seylers Z Physiol Chem. 1964;338:231–237. doi: 10.1515/bchm2.1964.338.1-2.231. [DOI] [PubMed] [Google Scholar]
  19. LANDERMAN N. S., WEBSTER M. E., BECKER E. L., RATCLIFFE H. E. Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein. J Allergy. 1962 Jul-Aug;33:330–341. doi: 10.1016/0021-8707(62)90032-1. [DOI] [PubMed] [Google Scholar]
  20. MACFARLANE R. G. AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. Nature. 1964 May 2;202:498–499. doi: 10.1038/202498a0. [DOI] [PubMed] [Google Scholar]
  21. MARGOLIS J. Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958 Nov 10;144(1):1–22. doi: 10.1113/jphysiol.1958.sp006082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MARGOLIS J. Hagerman factor and capillary permeability. Aust J Exp Biol Med Sci. 1959 Jun;37:239–244. doi: 10.1038/icb.1959.24. [DOI] [PubMed] [Google Scholar]
  23. Mirsky I. A. INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE). Science. 1944 Sep 1;100(2592):198–200. doi: 10.1126/science.100.2592.198. [DOI] [PubMed] [Google Scholar]
  24. NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
  25. PENSKY J., LEVY L. R., LEPOW I. H. Partial purification of a serum inhibitor of C'1-esterase. J Biol Chem. 1961 Jun;236:1674–1679. [PubMed] [Google Scholar]
  26. Prentice C. R., Breckenridge R. T., Ratnoff O. D. Studies on the conversion of prothrombin to thrombin: with notes on the cation requirement for this reaction. J Lab Clin Med. 1967 Feb;69(2):229–244. [PubMed] [Google Scholar]
  27. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. RATNOFF O. D., CONLEY C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull Johns Hopkins Hosp. 1951 Sep;89(3):245–254. [PubMed] [Google Scholar]
  29. RATNOFF O. D., CRUM J. D. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. J Lab Clin Med. 1964 Mar;63:359–377. [PubMed] [Google Scholar]
  30. RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. RATNOFF O. D., DAVIE E. W. The purification of activated Hageman factor (activated factor XII). Biochemistry. 1962 Nov;1:967–975. doi: 10.1021/bi00912a005. [DOI] [PubMed] [Google Scholar]
  32. RATNOFF O. D., LEPOW I. H. Some properties of an esterase derived from preparations of the first component of complement. J Exp Med. 1957 Aug 1;106(2):327–343. doi: 10.1084/jem.106.2.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. RATNOFF O. D., ROSENBLUM J. M. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958 Aug;25(2):160–168. doi: 10.1016/0002-9343(58)90023-8. [DOI] [PubMed] [Google Scholar]
  34. ROSEN F. S., PENSKY J., DONALDSON V., CHARACHE P. HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS. Science. 1965 May 14;148(3672):957–958. doi: 10.1126/science.148.3672.957. [DOI] [PubMed] [Google Scholar]
  35. Ratnoff O. D., Naff G. B. The conversion of C'IS to C'1 esterase by plasmin and trypsin. J Exp Med. 1967 Feb 1;125(2):337–358. doi: 10.1084/jem.125.2.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. TAYLOR F. B., Jr, FUDENBERG H. INHIBITION OF THE C'-1 COMPONENT OF COMPLEMENT BY AMINO ACIDS. Immunology. 1964 Jul;7:319–331. [PMC free article] [PubMed] [Google Scholar]
  37. WEBSTER M. E., ATNOFF O. D. Role of Hageman factor in the activation of vasodilator activity in human plasma. Nature. 1961 Oct 14;192:180–181. doi: 10.1038/192180a0. [DOI] [PubMed] [Google Scholar]
  38. WEBSTER M. E., PIERCE J. V. Action of the kallikreins on synthetic ester substrates. Proc Soc Exp Biol Med. 1961 May;107:186–191. doi: 10.3181/00379727-107-26575. [DOI] [PubMed] [Google Scholar]
  39. WEDGWOOD R. J. Measurement of the components of complement by the reagent titration technique. Z Immun exp ther. 1959 Oct-Nov;118:358–367. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES